DayOne Accelerator Program for Healthtech Startups 2026

🏥 About DayOne Accelerator Program for Healthtech Startups

The DayOne Accelerator is a 3-month hybrid program designed to support international, high-potential, early-stage ventures at the intersection of healthtech and pharma R&D. It aims to refine their value proposition, connect with key industry players, and accelerate their growth.

The top startups in each cohort have the chance to receive long-term support, space, and funding. The accelerator is based in Basel, Switzerland, Europe’s leading life sciences innovation hub.

🎁 Benefits of DayOne Accelerator Program

Participants of the DayOne Accelerator Program can expect the following benefits:

• Gain unparalleled access to pharma industry experts and key players in the Basel Area.
• Develop or refine your pharma-specific value proposition with hands-on mentorship.
• Tap into Basel’s world-class life sciences ecosystem, home to global pharma leaders.
• Potential access to the post-accelerator program, including:
  • CHF 50,000 in non-dilutive funding.
  • Up to CHF 50,000 in personalized support.
  • 12 months’ office space.
• Stay independent: the accelerator is equity-free and fee-free.

✅ Eligibility Criteria

The DayOne Accelerator is designed for founders who are serious about breaking into pharma. Eligible startups include:

• Healthtech and techbio startups enabling pharma R&D.
• Pre-Seed to Series A stage startups with less than $10M of dilutive funds raised to date.
• Startups aiming to collaborate or partner with pharma companies.

📅 Application Date and Process

• Application Deadline: 31 May, 2026.
• Interested applicants can apply through the official application website.

📄 Contact Information

For more details, visit the official DayOne Accelerator Program website.

• Gain unparalleled access to pharma industry experts and key players in the Basel Area
• Develop or refine your pharma-specific value proposition with hands-on mentorship
• Tap into Basel’s world-class life sciences ecosystem – home to global pharma leaders
• Potential to get access to the post-accelerator program, including CHF 50,000 in non-dilutive funding, up to CHF 50,000 in personalized support and 12 months’ office space
• Stay independent: our accelerator is equity-free and fee-free